Insight

Industrial Purity Specifications and COA Analysis for 5-Bromo-1,2,3-Trifluorobenzene

  • Typical industrial purity exceeds 99% with rigorous GC verification.
  • Optimized synthesis routes achieve yields up to 94.6% for cost efficiency.
  • Bulk procurement available with full regulatory compliance and safety data.

In the realm of advanced organic synthesis, fluorinated building blocks are critical for developing high-performance pharmaceuticals and liquid crystal materials. Among these, 5-Bromo-1,2,3-trifluorobenzene (CAS: 138526-69-9) stands out as a versatile intermediate. For procurement officers and process chemists, understanding the Certificate of Analysis (COA) is paramount to ensuring reaction consistency and final product quality. This document serves as the primary verification of industrial purity, confirming that the material meets the strict thresholds required for downstream applications.

As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to stringent quality control protocols. When evaluating supply chains, buyers must look beyond basic identity confirmation. A robust COA details gas chromatography (GC) area percentages, residual solvent limits, and moisture content. These parameters directly influence reaction kinetics, particularly in cross-coupling reactions where halogen stability is crucial.

Understanding COA Parameters for ≥99% Purity

The standard market specification for this fluorinated aromatic compound typically targets a minimum purity of 99%. However, high-grade pharmaceutical intermediates often require thresholds exceeding 99.5%. The COA must explicitly state the method of analysis, usually Gas Chromatography with Flame Ionization Detection (GC-FID). Key impurities to monitor include isomeric byproducts such as 1-Bromo-3,4,5-trifluorobenzene or unreacted starting materials like 1,2,3-trifluorobenzene.

Residual solvents are another critical metric. Given the synthesis involves organic phases, the COA should verify that solvents like dichloromethane are reduced to levels compliant with ICH Q3C guidelines. Furthermore, water content, determined by Karl Fischer titration, must be minimized to prevent hydrolysis during sensitive organometallic steps. A comprehensive COA ensures that the bulk price paid reflects material capable of high-yield transformations without extensive purification.

Key Quality Control Metrics: GC, Residual Solvents, and Halogen Stability

The chemical integrity of 3,4,5-Trifluorobromobenzene is defined by its physical and chemical properties. Process chemists must verify these against the provided COA to ensure compatibility with their specific synthesis route. The following table outlines the critical physical properties expected in a high-quality batch:

Property Specification Test Method
Appearance Colorless to Almost colorless liquid Visual
Purity (GC Area %) ≥ 99.0% GC-MS
Boiling Point 47-49 °C at 60 mm Hg Distillation
Density 1.767 g/mL at 25 °C Pychnometer
Refractive Index n20/D 1.482 Refractometry
Water Content ≤ 0.1% Karl Fischer

Halogen stability is particularly important for this molecule. The presence of three fluorine atoms and one bromine atom creates a specific electronic environment useful for nucleophilic aromatic substitution. However, improper storage can lead to degradation. The material should be stored sealed in dry conditions at room temperature, away from strong oxidizing agents. Hazard classifications indicate it is a flammable liquid (Category 3) and an irritant, necessitating careful handling during quality control sampling.

Comparing Industrial vs. Pharmaceutical-Grade Certificates of Analysis

While industrial grade material suffices for certain polymer applications, pharmaceutical intermediates demand higher scrutiny. The distinction often lies in the control of specific impurities rather than overall purity. For instance, heavy metal content and specific isomeric ratios are tightly controlled in pharma-grade batches. When sourcing high-purity 5-Bromo-1,2,3-trifluorobenzene, buyers should request batch-specific COAs that include trace metal analysis.

The manufacturing process significantly impacts these grades. A common efficient synthesis route involves the bromination of 1,2,3-trifluorobenzene using sodium bromide and sodium hypochlorite in a biphasic system. Optimized protocols can achieve yields around 94.6% with purity reaching 99.5% after recrystallization. In contrast, less controlled processes may result in lower yields and higher impurity profiles, affecting the bulk price value proposition. Manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. invest in process optimization to ensure consistent industrial purity across large-scale production runs.

Commercial Considerations and Supply Chain Stability

Procurement strategies for fluorinated building blocks must account for supply chain volatility. Market data suggests pricing benchmarks around $100.00 per kilogram for standard purity, though this fluctuates based on raw material costs and order volume. Minimum order quantities often start at 1KG for sampling, scaling to tons for commercial production. Reliable suppliers offer free samples to verify quality before committing to large contracts.

Supply ability is a critical factor. A capable global manufacturer should demonstrate the capacity to deliver from grams to tons without compromising quality. Lead times, packaging options (such as fluorinated bottles or steel drums), and shipping compliance (UN 1993) are essential logistical details to confirm. Ensuring the supplier provides a valid COA with every shipment maintains regulatory compliance and production continuity.

Conclusion

Securing high-quality 5-Bromo-1,2,3-trifluorobenzene requires a deep understanding of technical specifications and manufacturing capabilities. By prioritizing detailed COA analysis, verifying physical properties, and selecting a partner with robust synthesis capabilities, organizations can mitigate risk in their supply chain. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to delivering superior fluorinated intermediates that meet the rigorous demands of the global pharmaceutical and chemical industries.